Skip to main content
. 2023 Nov 21;12:e116. doi: 10.1017/jns.2023.100

Table 3.

Overall prevalence (using WHO international and WHO Asian cut-offs) and stratified prevalence (using WHO Asian cut-offs) of normal weight, overweight and obesity in Bangladesh, India, Pakistana

Bangladesh (n 1497) India (n 1161) Pakistan (n 1304)
Frequency prevalence (95 % CI) Prevalence of normal weight Prevalence of overweight Prevalence of obesity Prevalence of normal weight Prevalence of overweight Prevalence of obesity Prevalence of normal weight Prevalence of overweight Prevalence of obesity
Overall (WHO international cut-offs) 817/1497 405/1497 146/1497 506/1161 384/1161 205/1161 501/1304 406/1304 284/1304
54·6 (52·0–57·1) 27·1 (24·9–29·4) 9·8 (8·4–11·4) 43·6 (40·8–46·5) 33·1 (30·4–35·8) 17·7 (15·6–20·0) 38·4 (35·8–41·1) 31·1 (28·7–33·7) 21·8 (19·6–24·1)
Overall (WHO Asian cut-offs) 523/1497 294/1497 551/1497 290/1161 216/1161 589/1161 327/1304 174/1304 690/1304
34·9 (32·6–37·4) 19·6 (17·7–21·7) 36·8 (34·4–39·3) 25·0 (22·6–27·6) 18·6 (16·5–21·0) 50·7 (47·9–53·6) 25·1 (22·8–27·5) 13·3 (11·6–15·3) 52·9 (50·2–55·6)
Stratified prevalence (WHO Asian cut-offs):
Sex
Male 336/915 190/915 300/915 175/643 145/643 280/643 228/791 125/791 378/791
36·7 (33·7–39·9) 20·8 (18·3–23·5) 32·8 (29·8–35·9) 27·2 (23·9–30·8) 22·6 (19·5–25·9) 43·5 (39·8–47·4) 28·8 (25·8–32·1) 15·8 (13·4–18·5) 47·8 (44·3–51·3)
Female 187/582 104/582 251/582 115/518 71/518 309/518 99/513 49/513 312/513
32·1 (28·5–36·0) 17·9 (15·0–21·2) 43·1 (39·2–47·2) 22·2 (18·8–26·0) 13·7 (11·0–16·9) 59·7 (55·4–63·8) 19·3 (16·1–22·9) 9·6 (7·3–12·4) 60·8 (56·5–65·0)
Age group
18–24 years 196/432 76/432 113/432 53/120 17/120 38/120 76/158 20/158 37/158
45·4 (40·7–50·1) 17·6 (14·3–21·5) 26·2 (22·2–30·5) 44·2 (35·6–53·1) 14·2 (9·0–21·6) 31·7 (24·0–40·5) 48·1 (40·4–55·9) 12·7 (8·3–18·8) 23·4 (17·5–30·6)
25–39 years 232/731 147/731 296/731 109/531 101/531 294/531 156/599 91/599 301/599
31·7 (28·5–35·2) 20·1 (17·4–23·2) 40·5 (37·0–44·1) 20·5 (17·3–24·2) 19·0 (15·9–22·6) 55·4 (51·1–59·5) 26·0 (22·7–29·7) 15·2 (12·5–18·3) 50·3 (46·3–54·2)
40–54 years 71/263 56/263 119/263 90/382 72/382 195/382 63/399 44/399 271/399
27·0 (22·0–32·7) 21·3 (16·8–26·7) 45·2 (39·3–51·3) 23·6 (19·6–28·1) 18·8 (15·2–23·1) 51·0 (46·0–56·0) 15·8 (12·5–19·7) 11·0 (8·3–14·5) 67·9 (63·2–72·3)
55+ years 24/71 15/71 23/71 38/128 26/128 62/128 32/148 19/148 81/148
33·8 (23·8–45·5) 21·1 (13·2–32·1) 32·4 (22·6–44·1) 29·7 (22·4–38·2) 20·3 (14·2–28·2) 48·4 (39·9–57·1) 21·6 (15·7–29·0) 12·8 (8·3–19·3) 54·7 (46·7–62·6)
SMI
Bipolar disorder (any) 164/487 101/487 190/487 103/434 70/434 246/434 120/534 73/534 306/534
33·7 (29·6–38·0) 20·7 (17·4–24·6) 39·0 (34·8–43·4) 23·7 (20·0–28·0) 16·1 (13·0–19·9) 56·7 (52·0–61·3) 22·5 (19·1–26·2) 13·7 (11·0–16·9) 57·3 (53·1–61·4)
Major depressive disorder with psychotic features 22/76 17/76 33/76 12/63 17/63 34/63 155/595 69/595 311/595
28·9 (19·9–40·1) 22·4 (14·4–33·1) 43·4 (32·8–54·7) 19·0 (11·1–30·6) 27·0 (17·5–39·2) 54·0 (41·7–65·8) 26·1 (22·7–29·7) 11·6 (9·3–14·4) 52·3 (48·2–56·3)
Psychotic disorder 337/934 176/934 328/934 175/664 129/664 309/664 52/175 32/175 73/175
36·1 (33·1–39·2) 18·8 (16·5–21·5) 35·1 (32·1–38·2) 26·4 (23·1–29·8) 19·4 (16·6–22·6) 46·5 (42·8–50·3) 29·7 (23·4–36·9) 18·3 (13·2–24·7) 41·7 (34·6–49·2)
Setting
Inpatient 147/311 59/311 80/311 72/255 41/255 119/255 40/120 13/120 58/120
47·3 (41·8–52·8) 19·0 (15·0–23·7) 25·7 (21·2–30·9) 28·2 (23·0–34·1) 16·1 (12·1–21·1) 46·7 (40·6–52·8) 33·3 (25·5–42·2) 10·8 (6·4–17·8) 48·3 (39·5–57·2)
Outpatient 376/1186 235/1186 471/1186 218/906 175/906 470/906 287/1184 161/1184 632/1184
31·7 (29·1–34·4) 19·8 (17·6–22·2) 39·7 (37·0–42·5) 24·1 (21·4–27·0) 19·3 (16·9–22·0) 51·9 (48·6–55·1) 24·2 (21·9–26·8) 13·6 (11·8–15·7) 53·4 (50·5–56·2)
a

For participants where BMI was calculable (n = 3962 in total).